Park Sungchan, Hong Bumsik, Kim Choung-Soo, Ahn Hanjong
Department of Urology, Ulsan University College of Medicine, Asan Medical Center, Seoul, Korea.
J Urol. 2004 Feb;171(2 Pt 1):621-5. doi: 10.1097/01.ju.0000107767.56680.f7.
We assessed the impact of traditional prognostic factors and tumor location on the survival of patients treated for upper tract transitional cell carcinoma (TCC).
We retrospectively analyzed the data on 86 patients with upper tract TCC who underwent nephroureterectomy with a bladder cuff (95%) or parenchymal sparing surgery (5%). Mean patient age was 59.5 years and median followup was 43.8 months. The influence of traditional prognostic factors such as age, gender, tumor stage, grade and location on 5-year disease specific and recurrence-free (local recurrence or distant metastasis) survival rates was analyzed. The difference in survival rates between renal 45 pelvis and 41 ureteral cases was analyzed according to the respective T stage and grade.
Overall 5-year disease specific and recurrence-free survival rates were 83% and 72%, respectively. The significant prognostic factors for survival rates by univariate analysis were T stage, grade and location. N stage was significant for 5-year recurrence-free survival. On multivariate analysis tumor location was the only independent prognostic factor for the 2 survival rates, while N stage was significant for 5-year recurrence-free survival. Patients with ureteral tumor had a worse prognosis than those with pelvis tumor at the same stage or grade (p = 0.036).
Pelvis and ureteral TCC are not the same disease in terms of invasion and prognosis. Ureteral TCC is associated with a higher local or distant failure rate than renal pelvis TCC. A radical surgical approach including meticulous lymphadenectomy may be therapeutic in patients with invasive ureteral TCC.
我们评估了传统预后因素及肿瘤位置对上尿路移行细胞癌(TCC)患者生存情况的影响。
我们回顾性分析了86例接受肾输尿管膀胱袖状切除术(95%)或保留肾实质手术(5%)的上尿路TCC患者的数据。患者平均年龄为59.5岁,中位随访时间为43.8个月。分析了年龄、性别、肿瘤分期、分级及位置等传统预后因素对5年疾病特异性生存率及无复发生存率(局部复发或远处转移)的影响。根据各自的T分期和分级分析了45例肾盂病例与41例输尿管病例生存率的差异。
总体5年疾病特异性生存率和无复发生存率分别为83%和72%。单因素分析显示,生存率的显著预后因素为T分期、分级及位置。N分期对5年无复发生存率有显著影响。多因素分析显示,肿瘤位置是这两种生存率的唯一独立预后因素,而N分期对5年无复发生存率有显著影响。相同分期或分级的输尿管肿瘤患者比肾盂肿瘤患者预后更差(p = 0.036)。
肾盂和输尿管TCC在侵袭性和预后方面并非同一种疾病。输尿管TCC比肾盂TCC的局部或远处失败率更高。对于侵袭性输尿管TCC患者,包括细致淋巴结清扫的根治性手术方法可能具有治疗作用。